Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Childhood Kidney Tumors

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Childhood Kidney Tumors

Source population
pediatric
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      clinically-proposed
      derivation note
      Derived from NCI topic(s): Wilms Tumor and Other Childhood Kidney Tumors. Strongest NCIt resolution: candidate. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
      source wording
      Source null
      6 more-specific settings
      Stage I Childhood Kidney Tumors →Stage II Childhood Kidney Tumors →Stage III Childhood Kidney Tumors →Stage IV Childhood Kidney Tumors →Stage V Childhood Kidney Tumors →recurrent Childhood Kidney Tumors →

      Study evidence for this setting

      8 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00309907 · Registry condition search · Scope: narrower

      Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00408681 · Registry condition search · Scope: narrower

      Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00831844 · Registry condition search · Scope: narrower

      Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

      1 outcome links · 10 safety-group records · 0 quality-of-life measures

      →

      NCT01154816 · Registry condition search · Scope: narrower

      Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

      6 outcome links · 12 safety-group records · 0 quality-of-life measures

      →

      NCT01305200 · Registry condition search · Scope: narrower

      Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01502410 · Registry condition search · Scope: narrower

      Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01586104 · Registry condition search · Scope: narrower

      Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

      3 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01987596 · Registry condition search · Scope: narrower

      Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-childhood-kidney-tumors
        binding id
        ncit-C6563
        source collection
        ncit-concept
        source key
        C6563
        source excerpt
        Source null
        match status
        candidate
        match note
        Resolution status: candidate.
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice